Use of sodium nitroprusside in neonates: efficacy and safety (Q34195045)

31 July 2017

Use of sodium nitroprusside in neonates: efficacy and safety (English)

1 reference

31 July 2017

1 reference

Benitz WE

1

1 reference

31 July 2017

Malachowski N

2

1 reference

31 July 2017

Cohen RS

3

1 reference

31 July 2017

Stevenson DK

4

1 reference

31 July 2017

Ariagno RL

5

1 reference

31 July 2017

Sunshine P

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 1985

1 reference

The Journal of Pediatrics

31 July 2017

1 reference

31 July 2017

106

1 reference

31 July 2017

1

1 reference

31 July 2017

102-110

1 reference

Drug therapy. Sodium nitroprusside

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Sodium nitroprusside in children: Observations on metabolism during normal and abnormal responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Sodium nitroprusside treatment of severe arterial hypertension in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Afterload reduction and cardiac ouptut in infants early after intracardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Vasodilator therapy for congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Sodium nitroprusside in idiopathic respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Early use of sodium nitroprusside in respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Persistent pulmonary hypertension in the neonate: Diagnosis and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Hemodynamic effects of nitroprusside in infants with a large ventricular septal defect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Circulatory studies in clinical hyaline membrane disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Neonatal hypoxia and pulmonary vasospasm: Response to tolazoline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Refractory hypoxemia associated with neonatal pulmonary disease: The use and limitations of tolazoline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Pharmacologic alterations in pulmonary artery pressure in the adult respiratory distress syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Pulmonary vasodilator responses to nitroprusside and nitroglycerin in the dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Effect of sodium nitroprusside on hypoxic pulmonary vasoconstriction in the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Ventilation-Perfusion and Gas Exchange Effects of Sodium Nitroprusside in Dogs with Normal and Edematous Lungs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

High pulmonary vascular resistance after birth: I. Pathophysiologic considerations and etiologic classification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Cyanide and thiocyanate concentrations following sodium nitroprusside infusion in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

The toxicity of sodium nitroprusside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Sodium nitroprusside and RDS--primum non nocere

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Detoxification of cyanide in a new-born child

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Severe hypertension in newborn after pyeloplasty of hydronephrotic kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

Late morbidity among survivors of respiratory failure treated with tolazoline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980477-7

10.1016/S0022-3476(85)80477-7

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference